Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
Wang, XM; Wang, ZF; Chi, XM; Wu, RH; Jin, QL; Xu, HQ; Gao, XZ; Yu, L; Chen, YP; Shang, J; Liu, LG; Zhang, SQ; Jiang, YF; Zhang, MX; Tong, QX; Zhang, LL; Tan, YW; Ma, AL; Dang, SS; Xu, B; Jin, ZJ; Li, J; Li, XB; Lu, FM; Niu, JQ
Niu, JQ (corresponding author), First Hosp Jilin Univ, Dept Hepatol, Changchun 130021, Peoples R China.; Lu, FM (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, State Key Lab Nat & Biomimet Drugs,Dept Microbiol, Beijing 100083, Peoples R China.; Lu, FM (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Ctr Infect Dis, Beijing 100083, Peoples R China.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020; 99 (): 171
